Solid Biosciences (SLDB) Interest Expenses (2023 - 2025)
Solid Biosciences' (SLDB) quarterly Interest Expenses came in at $5000.0 in Q4 2025, down 93.33% year-on-year from $75000.0 in Q4 2024, and up 101.49% quarter-over-quarter from -$336000.0 in Q3 2025.
Solid Biosciences (SLDB) Interest Expenses (2023 - 2025) Analysis & Trends
Solid Biosciences has disclosed Interest Expenses across 3 years of filings, most recently posting $5000.0 for Q4 2025.
- Interest Expenses for Q4 2025 came in at $5000.0, down 93.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$271000.0 (down 186.58% YoY), and the FY2025 annual result was -$203000.0, down 159.71% from the prior year.
- Interest Expenses came in at $5000.0 for Q4 2025 at Solid Biosciences, up from -$336000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $121000.0 in Q1 2023 to a low of -$336000.0 in Q3 2025.
- The 3-year median for Interest Expenses is $85000.0 (2024), against an average of $48000.0.
- Across the five-year window, Interest Expenses declined 20.72% in 2024 and plunged 509.76% in 2025, its largest moves.
- Solid Biosciences' Interest Expenses stood at $101000.0 in 2023, then decreased by 25.74% to $75000.0 in 2024, then plunged by 93.33% to $5000.0 in 2025.
- The last three Interest Expenses figures came in at $5000.0 (Q4 2025), -$336000.0 (Q3 2025), and $60000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -336,000.00 |
| Sep 30, 2025 | -336,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 106,000.00 |
| Sep 30, 2023 | 106,000.00 |